397 related articles for article (PubMed ID: 10517506)
1. Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease.
Komori T
Brain Pathol; 1999 Oct; 9(4):663-79. PubMed ID: 10517506
[TBL] [Abstract][Full Text] [Related]
2. Glycogen synthase kinase-3 is associated with neuronal and glial hyperphosphorylated tau deposits in Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):583-91. PubMed ID: 12410379
[TBL] [Abstract][Full Text] [Related]
3. Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy.
Arai T; Ikeda K; Akiyama H; Shikamoto Y; Tsuchiya K; Yagishita S; Beach T; Rogers J; Schwab C; McGeer PL
Acta Neuropathol; 2001 Feb; 101(2):167-73. PubMed ID: 11271372
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Ferrer I; Blanco R; Carmona M; Ribera R; Goutan E; Puig B; Rey MJ; Cardozo A; Viñals F; Ribalta T
Brain Pathol; 2001 Apr; 11(2):144-58. PubMed ID: 11303790
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
6. Different immunoreactivities of the microtubule-binding region of tau and its molecular basis in brains from patients with Alzheimer's disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration.
Arai T; Ikeda K; Akiyama H; Tsuchiya K; Iritani S; Ishiguro K; Yagishita S; Oda T; Odawara T; Iseki E
Acta Neuropathol; 2003 May; 105(5):489-98. PubMed ID: 12677450
[TBL] [Abstract][Full Text] [Related]
7. Cellular tau pathology and immunohistochemical study of tau isoforms in sporadic tauopathies.
Yoshida M
Neuropathology; 2006 Oct; 26(5):457-70. PubMed ID: 17080726
[TBL] [Abstract][Full Text] [Related]
8. Anti-tau phospho-specific Ser262 antibody recognizes a variety of abnormal hyper-phosphorylated tau deposits in tauopathies including Pick bodies and argyrophilic grains.
Ferrer I; Barrachina M; Puig B
Acta Neuropathol; 2002 Dec; 104(6):658-64. PubMed ID: 12410387
[TBL] [Abstract][Full Text] [Related]
9. A double-labeling immunohistochemical study of tau exon 10 in Alzheimer's disease, progressive supranuclear palsy and Pick's disease.
Ishizawa K; Ksiezak-Reding H; Davies P; Delacourte A; Tiseo P; Yen SH; Dickson DW
Acta Neuropathol; 2000 Sep; 100(3):235-44. PubMed ID: 10965792
[TBL] [Abstract][Full Text] [Related]
10. [Neuropathology of tauopathy].
Yoshida M
Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
[TBL] [Abstract][Full Text] [Related]
11. Distinct involvement of the cranial and spinal nerves in progressive supranuclear palsy.
Tanaka H; Martinez-Valbuena I; Forrest SL; Couto B; Reyes NG; Morales-Rivero A; Lee S; Li J; Karakani AM; Tang-Wai DF; Tator C; Khadadadi M; Sadia N; Tartaglia MC; Lang AE; Kovacs GG
Brain; 2024 Apr; 147(4):1399-1411. PubMed ID: 37972275
[TBL] [Abstract][Full Text] [Related]
12. Astrocytic inclusions in progressive supranuclear palsy and corticobasal degeneration.
Yoshida M
Neuropathology; 2014 Dec; 34(6):555-70. PubMed ID: 25124031
[TBL] [Abstract][Full Text] [Related]
13. Motor neuron TDP-43 proteinopathy in progressive supranuclear palsy and corticobasal degeneration.
Riku Y; Iwasaki Y; Ishigaki S; Akagi A; Hasegawa M; Nishioka K; Li Y; Riku M; Ikeuchi T; Fujioka Y; Miyahara H; Sone J; Hattori N; Yoshida M; Katsuno M; Sobue G
Brain; 2022 Aug; 145(8):2769-2784. PubMed ID: 35274674
[TBL] [Abstract][Full Text] [Related]
14. Astrocytic plaques and tufts of abnormal fibers do not coexist in corticobasal degeneration and progressive supranuclear palsy.
Komori T; Arai N; Oda M; Nakayama H; Mori H; Yagishita S; Takahashi T; Amano N; Murayama S; Murakami S; Shibata N; Kobayashi M; Sasaki S; Iwata M
Acta Neuropathol; 1998 Oct; 96(4):401-8. PubMed ID: 9797005
[TBL] [Abstract][Full Text] [Related]
15. Deep learning-based model for diagnosing Alzheimer's disease and tauopathies.
Koga S; Ikeda A; Dickson DW
Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12759. PubMed ID: 34402107
[TBL] [Abstract][Full Text] [Related]
16. Neuropathology of frontotemporal lobar degeneration-tau (FTLD-tau).
Dickson DW; Kouri N; Murray ME; Josephs KA
J Mol Neurosci; 2011 Nov; 45(3):384-9. PubMed ID: 21720721
[TBL] [Abstract][Full Text] [Related]
17. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration.
Dickson DW
J Neurol; 1999 Sep; 246 Suppl 2():II6-15. PubMed ID: 10525997
[TBL] [Abstract][Full Text] [Related]
18. Selective tau tyrosine nitration in non-AD tauopathies.
Reyes JF; Geula C; Vana L; Binder LI
Acta Neuropathol; 2012 Jan; 123(1):119-32. PubMed ID: 22057784
[TBL] [Abstract][Full Text] [Related]
19. Cytoskeletal pathology in non-Alzheimer degenerative dementia: new lesions in diffuse Lewy body disease, Pick's disease, and corticobasal degeneration.
Dickson DW; Feany MB; Yen SH; Mattiace LA; Davies P
J Neural Transm Suppl; 1996; 47():31-46. PubMed ID: 8841955
[TBL] [Abstract][Full Text] [Related]
20. Contribution of the astrocytic tau pathology to synapse loss in progressive supranuclear palsy and corticobasal degeneration.
Briel N; Pratsch K; Roeber S; Arzberger T; Herms J
Brain Pathol; 2021 Jul; 31(4):e12914. PubMed ID: 33089580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
